IT1216762B - Composizione farmaceutica per somministrazione nasale. - Google Patents
Composizione farmaceutica per somministrazione nasale.Info
- Publication number
- IT1216762B IT1216762B IT8819541A IT1954188A IT1216762B IT 1216762 B IT1216762 B IT 1216762B IT 8819541 A IT8819541 A IT 8819541A IT 1954188 A IT1954188 A IT 1954188A IT 1216762 B IT1216762 B IT 1216762B
- Authority
- IT
- Italy
- Prior art keywords
- compsn
- calcitonin
- contg
- pharmaceutical
- pharmaceutical compsn
- Prior art date
Links
- 102000055006 Calcitonin Human genes 0.000 title abstract 2
- 108060001064 Calcitonin Proteins 0.000 title abstract 2
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title abstract 2
- 229960004015 calcitonin Drugs 0.000 title abstract 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- DDPFHDCZUJFNAT-PZPWKVFESA-N chembl2104402 Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 DDPFHDCZUJFNAT-PZPWKVFESA-N 0.000 abstract 1
- 108700032313 elcatonin Proteins 0.000 abstract 1
- 229960000756 elcatonin Drugs 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 229940074774 glycyrrhizinate Drugs 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8819541A IT1216762B (it) | 1988-02-25 | 1988-02-25 | Composizione farmaceutica per somministrazione nasale. |
| EP88310560A EP0327756B1 (en) | 1987-11-13 | 1988-11-10 | Pharmaceutical compositions comprising a calcitonin and a glycyrrhizinate as absorption enhancer |
| ES88310560T ES2061688T3 (es) | 1987-11-13 | 1988-11-10 | Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion. |
| GB8826321A GB2212062B (en) | 1987-11-13 | 1988-11-10 | Pharmaceutical compositions containing a calcitonin and a glycyrrhizinate ab- sorption enhancer |
| DE3887494T DE3887494T2 (de) | 1987-11-13 | 1988-11-10 | Ein Calcitonin sowie ein Glycyrrhizinat als Absorptionsförderer enthaltende Arzneimittel. |
| IE339088A IE61913B1 (en) | 1987-11-13 | 1988-11-11 | Pharmaceutical compositions comprising a calcitonin and a glycyrrhizinate as absorption enhancer |
| US07/270,905 US5183802A (en) | 1987-11-13 | 1988-11-14 | Pharmaceutical compositions for intranasal administration of calcitonin |
| MX9203725A MX9203725A (es) | 1987-11-13 | 1992-06-29 | Composiciones farmaceuticas que comprenden una calcitonina y un glicirrizinato como aumentador de absorcion. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8819541A IT1216762B (it) | 1988-02-25 | 1988-02-25 | Composizione farmaceutica per somministrazione nasale. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8819541A0 IT8819541A0 (it) | 1988-02-25 |
| IT1216762B true IT1216762B (it) | 1990-03-08 |
Family
ID=11158900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT8819541A IT1216762B (it) | 1987-11-13 | 1988-02-25 | Composizione farmaceutica per somministrazione nasale. |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1216762B (it) |
-
1988
- 1988-02-25 IT IT8819541A patent/IT1216762B/it active Protection Beyond IP Right Term
Also Published As
| Publication number | Publication date |
|---|---|
| IT8819541A0 (it) | 1988-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nutton | From Galen to Alexander, aspects of medicine and medical practice in late antiquity | |
| KR910016317A (ko) | 이온전기도입에 의한 딜리버리를 증가시키는 방법 및 여기에 사용되는 조성물 | |
| AU562938B2 (en) | 7, 10, 13, 16 docosatetraenoic acid composition | |
| EP1181929A3 (en) | Method of potentiating an immune response and compositions therefor | |
| HK1012230A1 (en) | Rapamycin formulations for iv injection | |
| NZ223559A (en) | Recovery of protein, renaturation processes | |
| ATE148165T1 (de) | Stabilisierung von hochgereinigten proteinen | |
| SE8700137L (sv) | Diuretisk komposition | |
| GR900100612A (en) | Compositions for local use | |
| IL94652A0 (en) | Carboplatin composition | |
| GB8622012D0 (en) | Solid iodophor composition | |
| IT1239282B (it) | Soluzione acquosa contenente acido cromoglicico e salbutamol, oppure sali farmaceuticamente accettabili | |
| IT1216762B (it) | Composizione farmaceutica per somministrazione nasale. | |
| GR3004303T3 (it) | ||
| ATE65022T1 (de) | Konservierte augentropfen mit einem gehalt an cromoglycinsaeure. | |
| JPS6483254A (en) | Metal surface treatment agent for adhesion | |
| MY104345A (en) | Pharmaceutical compositions | |
| DE69331385D1 (de) | Zusammensetzung zur hautbehandlung | |
| MY102425A (en) | Preservative for wood | |
| IT8821145V0 (it) | Dispositivo di fissaggio per rotelle sterzanti, in particolare di contenitori d'immondizia con serratura di sicurezza. | |
| ZA891360B (en) | A solution of carboplatin | |
| FR2227278A1 (en) | Separation of secretin and cholecystoquinine - using a resin | |
| RO103109A2 (en) | Composition for producing liposomes usable in cosmetic | |
| CA2153071A1 (en) | Derivatized calcitonins | |
| Putman | Three sources of fear in the works of Stephen King |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ITCP | Complementary protection certificate |
Free format text: CCP 253 |
|
| MEDD | Supplementary protection certificate for pharmaceutical products: granted |
Free format text: CCP 253, 19920508; ISF S.P.A |
|
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19990226 |